So Jung Han
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
So Jung Han has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Jae Jun Park
Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
5 shared publications - Soo Jung Park
Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
5 shared publications - Jae Hee Cheon
Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
4 shared publications - Jihye Park
Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
3 shared publications - Tae Il Kim
Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
3 shared publications - Byong Duk Ye
Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
2 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by Korean Association for the Study of Intestinal Diseases in Intestinal Research
- Vol. 24 (4) , 735-743
Clinical usefulness of fecal calprotectin in assessing disease activity and endoscopic remission in intestinal Behçet’s disease
Background/Aims: Intestinal Behçet’s disease (BD) is a manifestation of BD involving the gastrointestinal tract. Although fecal calprotectin (FC) is a useful inflammatory marker, its role in intestinal BD is unclear. Methods: We retrospectively analyzed 78 patients with intestinal BD to evaluate correlations between FC levels and the Disease Activity Index for Intestinal Behçet’s Disease (DAIBD), C-reactive protein (CRP), and erythrocyte sedimentation rate. FC and CRP levels were compared between patients in endoscopic remission and those with active disease. Receiver operating characteristic (ROC) curve analysis was used to evaluate FC’s ability to predict endoscopic activity and ulcer size. Results: FC levels significantly correlated with DAIBD scores (r= 0.253, P= 0.025) and CRP (r= 0.227, P= 0.046). Patients with endoscopically active disease had higher FC (1,124 ± 1,957 μg/g vs. 367 ± 1,208 μg/g; P< 0.001) and CRP levels (16.0 ± 23.7 mg/L vs. 14.4 ± 46.5 mg/L; P= 0.027) than those in remission. Patients with larger ulcers ( ≥ 30 mm) had higher FC levels than those with smaller ulcers (2,212 ± 2,609 μg/g vs. 962 ± 1,822 μg/g; P= 0.034). An FC cutoff level of 176 μg/g discriminated active endoscopic disease (sensitivity 59.3%, specificity 83.3%), with an area under the ROC curve (AUC) of 0.724 (95% confidence interval, 0.605–0.843; P= 0.002), outperforming CRP (AUC, 0.657).Conclusions: FC levels correlated with DAIBD scores and endoscopic inflammation in intestinal BD. FC outperformed CRP in detecting endoscopic activity, supporting its use in disease management.
- 31 October 2026
- Published by Korean Association for the Study of Intestinal Diseases in Intestinal Research
- Vol. 24 (4) , 735-743
Open AccessClinical usefulness of fecal calprotectin in assessing disease activity and endoscopic remission in intestinal Behçet’s disease
Background/Aims: Intestinal Behçet’s disease (BD) is a manifestation of BD involving the gastrointestinal tract. Although fecal calprotectin (FC) is a useful inflammatory marker, its role in intestinal BD is unclear. Methods: We retrospectively analyzed 78 patients with intestinal BD to evaluate correlations between FC levels and the Disease Activity Index for Intestinal Behçet’s Disease (DAIBD), C-reactive protein (CRP), and erythrocyte sedimentation rate. FC and CRP levels were compared between patients in endoscopic remission and those with active disease. Receiver operating characteristic (ROC) curve analysis was used to evaluate FC’s ability to predict endoscopic activity and ulcer size. Results: FC levels significantly correlated with DAIBD scores (r= 0.253, P= 0.025) and CRP (r= 0.227, P= 0.046). Patients with endoscopically active disease had higher FC (1,124 ± 1,957 μg/g vs. 367 ± 1,208 μg/g; P< 0.001) and CRP levels (16.0 ± 23.7 mg/L vs. 14.4 ± 46.5 mg/L; P= 0.027) than those in remission. Patients with larger ulcers ( ≥ 30 mm) had higher FC levels than those with smaller ulcers (2,212 ± 2,609 μg/g vs. 962 ± 1,822 μg/g; P= 0.034). An FC cutoff level of 176 μg/g discriminated active endoscopic disease (sensitivity 59.3%, specificity 83.3%), with an area under the ROC curve (AUC) of 0.724 (95% confidence interval, 0.605–0.843; P= 0.002), outperforming CRP (AUC, 0.657).Conclusions: FC levels correlated with DAIBD scores and endoscopic inflammation in intestinal BD. FC outperformed CRP in detecting endoscopic activity, supporting its use in disease management.
- Open Access
- 19 August 2026
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (6) , 1017-1025
Clinical Usefulness of Computed Tomography Enterography as a Diagnostic Modality for Isolated Terminal Ileitis
Woojin Ahn, Jung Hyun Ji, Seoyoon Choi, So Jung Han, Jihye Park, Soo Jung Park, Jae Hee Cheon, Tae Il Kim, Jae Jun Park. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl250584
- 19 August 2026
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (6) , 1017-1025
Open AccessClinical Usefulness of Computed Tomography Enterography as a Diagnostic Modality for Isolated Terminal Ileitis
Woojin Ahn, Jung Hyun Ji, Seoyoon Choi, So Jung Han, Jihye Park, Soo Jung Park, Jae Hee Cheon, Tae Il Kim, Jae Jun Park. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl250584
- Open Access
- 4 February 2026
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 41 (1) , 57
Impact of gross tumor morphology on the clinical outcomes of colon cancer: multicenter retrospective cohort study
Purpose: While histopathological features are established prognostic factors in colorectal cancer, the prognostic significance of gross tumor morphology remains unclear. We investigated whether endoscopic gross morphology is associated with clinical outcomes in colon cancer. Methods: We performed a multicenter retrospective analysis of 1,177 patients with colon cancer who underwent curative-intent endoscopic or surgical resection between 2010 and 2019. Tumors were categorized based on endoscopic images as flat/ulceroinfiltrative ( n = 345) or fungating/ulcerofungating ( n = 832). Kaplan–Meier analysis assessed survival outcomes, and Cox proportional hazards models identified independent prognostic factors, adjusting for age, sex, family history, diabetes, CEA, and AJCC 7th edition stage. Results: Patients with flat/ulceroinfiltrative tumors had significantly shorter overall survival (OS, p = 0.001) and disease-free survival (DFS, p = 0.024) than those with fungating/ulcerofungating tumors. In stage II patients, the difference in OS by morphology was more pronounced ( p = 0.004). Multivariate analysis confirmed flat/ulceroinfiltrative morphology as an independent predictor of poor OS (HR 1.61; 95% CI 1.122–2.335; p = 0.010). Other significant predictors included older age (≥ 65 years, HR 1.533; p = 0.021), poor histologic grade (PD vs. WD/MD, HR 5.308; p < 0.001), and advanced stage. Conclusions: Gross endoscopic morphology is an independent prognostic factor in colon cancer. Flat/ulceroinfiltrative tumors are associated with worse outcomes, especially in stage II disease. Gross morphology, readily identifiable at diagnosis, may aid risk stratification and inform decisions regarding adjuvant therapy.
- 4 February 2026
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 41 (1) , 57
Open AccessImpact of gross tumor morphology on the clinical outcomes of colon cancer: multicenter retrospective cohort study
Purpose: While histopathological features are established prognostic factors in colorectal cancer, the prognostic significance of gross tumor morphology remains unclear. We investigated whether endoscopic gross morphology is associated with clinical outcomes in colon cancer. Methods: We performed a multicenter retrospective analysis of 1,177 patients with colon cancer who underwent curative-intent endoscopic or surgical resection between 2010 and 2019. Tumors were categorized based on endoscopic images as flat/ulceroinfiltrative ( n = 345) or fungating/ulcerofungating ( n = 832). Kaplan–Meier analysis assessed survival outcomes, and Cox proportional hazards models identified independent prognostic factors, adjusting for age, sex, family history, diabetes, CEA, and AJCC 7th edition stage. Results: Patients with flat/ulceroinfiltrative tumors had significantly shorter overall survival (OS, p = 0.001) and disease-free survival (DFS, p = 0.024) than those with fungating/ulcerofungating tumors. In stage II patients, the difference in OS by morphology was more pronounced ( p = 0.004). Multivariate analysis confirmed flat/ulceroinfiltrative morphology as an independent predictor of poor OS (HR 1.61; 95% CI 1.122–2.335; p = 0.010). Other significant predictors included older age (≥ 65 years, HR 1.533; p = 0.021), poor histologic grade (PD vs. WD/MD, HR 5.308; p < 0.001), and advanced stage. Conclusions: Gross endoscopic morphology is an independent prognostic factor in colon cancer. Flat/ulceroinfiltrative tumors are associated with worse outcomes, especially in stage II disease. Gross morphology, readily identifiable at diagnosis, may aid risk stratification and inform decisions regarding adjuvant therapy.
- Open Access
- 1 January 2024
- Published by XMLink in Yonsei Medical Journal
- Vol. 65 (5) , 265-275
Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study
Park JB, et al. Yonsei Med J. 2024 May;65(5):265-275. https://doi.org/10.3349/ymj.2023.0321
- 1 January 2024
- Published by XMLink in Yonsei Medical Journal
- Vol. 65 (5) , 265-275
Open AccessOptimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study
Park JB, et al. Yonsei Med J. 2024 May;65(5):265-275. https://doi.org/10.3349/ymj.2023.0321
- Open Access
- 1 January 2023
- Published by XMLink in Yonsei Medical Journal
- Vol. 64 (2) , 111-116
Risk Factors for Surgery in Patients with Intestinal Behçet’s Disease During Anti-Tumor Necrosis Factor-Alpha Therapy
Han SJ, et al. Yonsei Med J. 2023 Jan;64:e10. https://doi.org/10.3349/ymj.2022.0264
- 1 January 2023
- Published by XMLink in Yonsei Medical Journal
- Vol. 64 (2) , 111-116
Open AccessRisk Factors for Surgery in Patients with Intestinal Behçet’s Disease During Anti-Tumor Necrosis Factor-Alpha Therapy
Han SJ, et al. Yonsei Med J. 2023 Jan;64:e10. https://doi.org/10.3349/ymj.2022.0264
- Open Access
- 1 December 2021
- Published by Korean Society of Gastrointestinal Cancer Research in Journal of Digestive Cancer Research
- Vol. 9 (2) , 68-70
Multiple Rectal Neuroendocrine Tumor
So Jung Han, Jun Yong Kim, Jae Jun Park. Journal of Digestive Cancer Reports 2021;9:68-70. https://doi.org/10.52927/jdcr.2021.9.2.68
- 1 December 2021
- Published by Korean Society of Gastrointestinal Cancer Research in Journal of Digestive Cancer Research
- Vol. 9 (2) , 68-70
Open AccessMultiple Rectal Neuroendocrine Tumor
So Jung Han, Jun Yong Kim, Jae Jun Park. Journal of Digestive Cancer Reports 2021;9:68-70. https://doi.org/10.52927/jdcr.2021.9.2.68